Researchers discover unexpected role of an immune system receptor; blocking it halts human cancer cell growth and improves survival in animal models
For some cancers, initial treatment with chemotherapy brings positive, but only temporary, results: tumors shrink, but then rebound as the cancer becomes drug-resistant. This pattern of remission-resistance-relapse is particularly true for pancreatic cancer, an aggressive disease in which early success is often countered by eventual disease progression.
To wit: The one-year relative survival rate for pancreatic cancer is 20 percent, according to the American Cancer Society. The five-year rate is just 7 percent.
The reason: Current multidrug chemotherapy regimens targeting pancreatic cancer typically do not fully eradicate all cancer cells, leaving behind drug-resistant cells that harbor aberrant stem cell properties and can drive tumor regrowth and metastasis.
In a new paper publishing in the April 4, 2019 online issue of Cell, an international team of scientists led by researchers at University of California San Diego School of Medicine employed an array of next-generation sequencing and gene-editing tools, such as CRISPR, to map the molecular dependencies —and thus vulnerabilities — of pancreatic cancer stem cells.
Most notably, they found that a key hormone receptor called retinoic acid receptor-related orphan receptor gamma or ROR?, previously studied in inflammation and T-cell differentiation, was especially active during pancreatic cancer progression, and that blocking it markedly slowed patient derived tumor growth and improved survival in animal models.
“These studies revealed an unexpected role for immuno-regulatory genes in the maintenance of the most aggressive, drug-resistant cells in pancreatic cancer,” said senior study author Tannishtha Reya, PhD, UC San Diego professor in the departments of Pharmacology and Medicine. In particular, ROR? emerged as a key regulator. ROR? rose with cancer progression and its inhibition through genetic and pharmacological approaches resulted in a striking defect in pancreatic cancer growth.
“Our work shows that immune system signals are hijacked by pancreatic cancer, and suggests that therapies currently being tested for autoimmune indications should be considered for testing in pancreatic cancer,” said Reya.
Using genome scale approaches to map stem cell dependencies in pancreatic cancer “will be invaluable for understanding the basis of therapy resistance and recurrence and for discovering new vulnerabilities in pancreatic cancer,” said Reya. “Beyond providing new scientific insight, this work can help identify pathways for which clinical grade inhibitors may already exist and can thus be rapidly tested in pancreatic cancer.”
In particular, she said the discovery of ROR?‘s role in promoting tumor growth provides a new avenue for research and potential therapies. “One exciting aspect is the possibility that nuclear hormone receptors could represent therapeutic targets for pancreatic cancer. In fact, drugs targeting ROR? have already been developed by several pharmaceutical companies, and are in trials for autoimmune diseases. Our findings suggest that these agents could also be a valuable therapeutic strategy for pancreatic cancer.”
The Latest on: Pancreatic cancer
[google_news title=”” keyword=”pancreatic cancer” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Pancreatic cancer
- What Are The Reasons For Pancreatic Cancer? What Harvard Health Publishing And More Doctors Think.on December 3, 2023 at 3:44 am
Answered by Dr. Howard E. Lewine M.D. Chief Medical Editor, Harvard Health Publishing · 40 years of experience · USA For most types of pancreatic cancer, there is no proven way to prevent it. You can ...
- Yellowness of eyes is also a symptom of pancreatic cancer, identify it in time and prevent iton December 2, 2023 at 3:15 am
In a world where health is of paramount importance, understanding the subtle signs that your body might be sending is crucial. One such sign..|News Track ...
- What Is Pancreatic Cancer? Causes, Symptoms, Treatment And All You Need To Knowon December 2, 2023 at 12:48 am
The pancreas, a small organ situated deep within the abdomen, often goes unnoticed until it becomes a source of health concern. Responsible for producing digestive enzymes and regulating blood sugar, ...
- Letter to the editor: November Pancreatic Cancer Awareness Monthon December 1, 2023 at 5:22 am
Governor Sununu issued a proclamation declaring November Pancreatic Cancer Awareness Month. As a volunteer for the Boston Affiliate of the Pancreatic Cancer Action Network (PanCAN), I want to bring ...
- 'Time matters' says pancreatic cancer survivor as partnership for 'faster' care announcedon November 30, 2023 at 10:47 am
A pancreatic cancer survivor has welcomed the announcement of a new partnership aimed at improving outcomes for patients in Northern Ireland. Lisburn man Tom Hawthorne says "time matters" when it ...
- Pancreatic cancer survivor feels 'extremely lucky' to be aliveon November 30, 2023 at 6:08 am
A man who was diagnosed with pancreatic cancer six years ago has said he feels "extremely lucky" to still be alive after his symptoms were caught in time for life-saving treatment.
- What Is Pancreatic Cancer: Types Causes and Analysison November 30, 2023 at 2:22 am
Pancreatic cancer starts when irregular cells within the pancreas develop and divide out of control and shape a tumor. The pancreas could be an organ found deep within the abdomen, between the stomach ...
- The Pancreatic Puzzle: Cracking the Code of Cancer’s Immune Secretson November 29, 2023 at 4:52 am
Recent findings at Cold Spring Harbor Laboratory (CSHL) shine a new light on pancreatic cancer. Cold Spring Harbor Laboratory researchers have uncovered that pancreatic cancer elicits an immune ...
- Pancreatic cancer triggers immune response, but disease-fighting T cells may not easily infiltrate PDAC tumors: Studyon November 28, 2023 at 4:00 pm
Recent findings at Cold Spring Harbor Laboratory (CSHL) shine a new light on pancreatic cancer. More than 90% of pancreatic cancer cases are attributed to an aggressive, deadly form of the disease ...
- Pancreatic Cancer Awareness Month: Watch Out For These Uncommon Signs Of Pancreatic Canceron November 25, 2023 at 11:00 pm
November is observed as pancreatic cancer awareness month. Learn some surprising initial signs of pancreatic cancer.
via Bing News